- Report
- February 2025
- 183 Pages
Global
From €4278EUR$4,500USD£3,594GBP
- Report
- February 2025
- 182 Pages
Global
From €4278EUR$4,500USD£3,594GBP
- Report
- February 2025
- 185 Pages
Global
From €4278EUR$4,500USD£3,594GBP
- Report
- January 2025
- 180 Pages
Global
From €4278EUR$4,500USD£3,594GBP
- Report
- January 2025
- 185 Pages
Global
From €4278EUR$4,500USD£3,594GBP
- Report
- January 2025
- 185 Pages
Global
From €4278EUR$4,500USD£3,594GBP
- Report
- October 2024
- 183 Pages
Global
From €4278EUR$4,500USD£3,594GBP
- Report
- September 2024
- 183 Pages
Global
From €4278EUR$4,500USD£3,594GBP
- Report
- July 2024
- 190 Pages
Global
From €4278EUR$4,500USD£3,594GBP
- Report
- July 2024
- 185 Pages
Global
From €4278EUR$4,500USD£3,594GBP
- Report
- July 2024
- 181 Pages
Global
From €4278EUR$4,500USD£3,594GBP
- Report
- May 2024
- 185 Pages
Global
From €4278EUR$4,500USD£3,594GBP
- Report
- May 2024
- 184 Pages
Global
From €4278EUR$4,500USD£3,594GBP
- Report
- May 2024
- 185 Pages
Global
From €4278EUR$4,500USD£3,594GBP
- Report
- April 2024
- 185 Pages
Global
From €4278EUR$4,500USD£3,594GBP
- Report
- August 2024
- 166 Pages
Global
From €2377EUR$2,500USD£1,997GBP
- Report
- May 2024
- 166 Pages
Global
From €2377EUR$2,500USD£1,997GBP
- Report
- May 2024
- 159 Pages
Global
From €2377EUR$2,500USD£1,997GBP
- Report
- August 2024
- 166 Pages
Global
From €2377EUR$2,500USD£1,997GBP
- Report
- June 2024
- 196 Pages
Global
From €2377EUR$2,500USD£1,997GBP

Biomedicine is a branch of biotechnology that focuses on the development of medical treatments and products. It involves the use of living organisms, such as bacteria, viruses, and cells, to create treatments and products that can be used to diagnose, prevent, and treat diseases. Biomedicine also includes the development of medical devices, such as prosthetics, and the use of genetic engineering to create new treatments.
Biomedicine is a rapidly growing field, with many companies investing in research and development. Companies in the biomedicine market are focused on developing treatments and products for a variety of diseases, including cancer, diabetes, and cardiovascular diseases. They are also working to develop treatments for rare diseases and to improve existing treatments.
Some of the companies in the biomedicine market include AbbVie, Amgen, AstraZeneca, Biogen, Bristol-Myers Squibb, Celgene, Gilead Sciences, Johnson & Johnson, Merck, Novartis, Pfizer, and Roche. Show Less Read more